Inhibitors of cathepsin C (dipeptidyl peptidase I)

Author： Laine Dramane I   Busch-Petersen Jakob  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.4, 2010-04, pp. : 497-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes

By Ahrén Bo  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 593-607

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of Dipeptidyl Peptidase-4 Inhibitors: Similarities and Differences

By Baetta Roberta   Corsini Alberto  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1441-1467

Adis International

Access to resources Recommend Favorite

Recent patents of dipeptidyl peptidase IV inhibitors

By Mendieta Laura   Tarrago Teresa   Giralt Ernest  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1693-1741

Informa Healthcare

Access to resources Recommend Favorite

Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV

By Augustyns K.   Lambeir A.   Borloo M.   De Meester I.   Vedernikova I.   Vanhoof G.   Hendriks D.   Scharpe S.   Haemers A.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 4, 1997-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis

By Scheen Andre  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 545-557

Informa Healthcare

Access to resources Recommend Favorite